| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP38 USP17L17 USP17L3 USP35 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP26 USP17L6P USP17L22 USP17L15 | 1.27e-20 | 114 | 206 | 21 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP38 USP17L17 USP17L3 USP35 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP26 USP17L6P USP17L22 USP17L15 | 8.05e-20 | 124 | 206 | 21 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP38 USP17L17 USP17L3 USP35 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP26 USP17L6P USP17L22 USP17L15 | 6.97e-19 | 137 | 206 | 21 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP38 USP17L17 USP17L3 USP35 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP26 USP17L6P USP17L22 USP17L15 | 8.25e-16 | 192 | 206 | 21 | GO:0008234 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP38 USP17L17 USP17L3 USP35 ERVK-25 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP26 USP17L6P USP17L22 USP17L15 | 1.20e-06 | 654 | 206 | 22 | GO:0008233 |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF21B ATP5PO SMC1A CFTR PEX1 ATP10B MDN1 DNA2 ATP8B3 DNAH3 IPO8 NSF DHX37 DHX40 DNAH2 MYO18A SAE1 HELQ DNAH1 DNAH17 | 6.10e-06 | 614 | 206 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF21B ATP5PO SMC1A CFTR PEX1 ATP10B MDN1 DNA2 ATP8B3 DNAH3 NSF DHX37 DHX40 DNAH2 MYO18A HELQ | 1.46e-05 | 441 | 206 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 1.79e-05 | 32 | 206 | 5 | GO:0015106 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.01e-05 | 18 | 206 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | choline transmembrane transporter activity | 5.83e-05 | 8 | 206 | 3 | GO:0015220 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.86e-04 | 28 | 206 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF21B ATP5PO SMC1A CFTR PEX1 ATP10B RAB6C MDN1 GNAO1 DNA2 RAB6D ATP8B3 DNAH3 NSF DHX37 DHX40 DNAH2 MYO18A HELQ | 4.43e-04 | 775 | 206 | 19 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | KIF21B ATP5PO SMC1A CFTR PEX1 ATP10B RAB6C MDN1 GNAO1 DNA2 RAB6D ATP8B3 DNAH3 NSF DHX37 DHX40 DNAH2 MYO18A HELQ NUDT13 | 4.47e-04 | 839 | 206 | 20 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KIF21B ATP5PO SMC1A CFTR PEX1 ATP10B RAB6C MDN1 GNAO1 DNA2 RAB6D ATP8B3 DNAH3 NSF DHX37 DHX40 DNAH2 MYO18A HELQ NUDT13 | 4.54e-04 | 840 | 206 | 20 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KIF21B ATP5PO SMC1A CFTR PEX1 ATP10B RAB6C MDN1 GNAO1 DNA2 RAB6D ATP8B3 DNAH3 NSF DHX37 DHX40 DNAH2 MYO18A HELQ NUDT13 | 4.54e-04 | 840 | 206 | 20 | GO:0016818 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 5.57e-04 | 37 | 206 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | anandamide 8,9 epoxidase activity | 6.27e-04 | 4 | 206 | 2 | GO:0062187 | |
| GeneOntologyMolecularFunction | anandamide 11,12 epoxidase activity | 6.27e-04 | 4 | 206 | 2 | GO:0062188 | |
| GeneOntologyMolecularFunction | steroid 21-monooxygenase activity | 6.27e-04 | 4 | 206 | 2 | GO:0004509 | |
| GeneOntologyMolecularFunction | progesterone 21-hydroxylase activity | 6.27e-04 | 4 | 206 | 2 | GO:0106309 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 6.98e-04 | 103 | 206 | 6 | GO:0005253 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 7.82e-04 | 70 | 206 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 9.90e-04 | 151 | 206 | 7 | GO:0008509 | |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 1.04e-03 | 5 | 206 | 2 | GO:0008294 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.42e-03 | 118 | 206 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | anandamide 14,15 epoxidase activity | 1.55e-03 | 6 | 206 | 2 | GO:0062189 | |
| GeneOntologyMolecularFunction | anandamide epoxidase activity | 1.55e-03 | 6 | 206 | 2 | GO:0062186 | |
| GeneOntologyMolecularFunction | ankyrin binding | 1.65e-03 | 23 | 206 | 3 | GO:0030506 | |
| GeneOntologyMolecularFunction | C-C chemokine receptor activity | 1.65e-03 | 23 | 206 | 3 | GO:0016493 | |
| GeneOntologyMolecularFunction | transporter activity | TRPM6 ATP5PO BEST2 CETP CFTR PEX1 ATP10B BCL2A1 CHRNG SLC26A8 SLC44A5 KCNQ2 TMCO3 RHCG LRRC8C ATP8B3 ANO2 STIM2 SLC4A7 IPO8 SLC44A2 SLC44A4 SLC1A4 SLC39A12 SLCO2A1 | 1.76e-03 | 1289 | 206 | 25 | GO:0005215 |
| GeneOntologyMolecularFunction | C-C chemokine binding | 1.87e-03 | 24 | 206 | 3 | GO:0019957 | |
| GeneOntologyMolecularFunction | chloride channel activity | 1.97e-03 | 86 | 206 | 5 | GO:0005254 | |
| GeneOntologyMolecularFunction | G protein-coupled chemoattractant receptor activity | 2.36e-03 | 26 | 206 | 3 | GO:0001637 | |
| GeneOntologyMolecularFunction | chemokine receptor activity | 2.36e-03 | 26 | 206 | 3 | GO:0004950 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP38 USP17L17 USP17L3 USP35 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP26 USP17L6P USP17L22 USP17L15 | 5.00e-20 | 125 | 206 | 21 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP38 USP17L17 USP17L3 USP35 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP26 USP17L6P USP17L22 USP17L15 | 1.06e-18 | 144 | 206 | 21 | GO:0070646 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 HSPBP1 ZZEF1 USP17L18 USP38 USP17L17 USP17L3 USP35 HERC2 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 SAE1 USP17L5 HUWE1 RWDD3 USP26 RNF123 FANCI USP17L6P UBR3 TNFAIP1 USP17L22 USP17L15 CDK5 | 6.62e-09 | 1009 | 206 | 32 | GO:0070647 |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 HSPBP1 ZZEF1 USP17L18 USP38 USP17L17 USP17L3 USP35 HERC2 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 SAE1 USP17L5 HUWE1 RWDD3 USP26 RNF123 FANCI USP17L6P UBR3 TNFAIP1 USP17L22 USP17L15 CDK5 | 2.89e-08 | 1074 | 206 | 32 | GO:0043687 |
| GeneOntologyBiologicalProcess | bicarbonate transport | 3.63e-05 | 38 | 206 | 5 | GO:0015701 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 9.85e-05 | 25 | 206 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.08e-04 | 10 | 206 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L7 PIGN USP17L21 CYP2A7 CYP2D6 USP17L1 USP17L20 SEC24A CFTR ATP10B USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 LRRC8C ATP8B3 USP17L4 STIM2 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P STARD3NL USP17L22 USP17L15 | 1.82e-04 | 1293 | 206 | 27 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L7 PIGN USP17L21 CYP2A7 CYP2D6 USP17L1 USP17L20 SEC24A CFTR ATP10B USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 LRRC8C ATP8B3 USP17L4 STIM2 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P STARD3NL USP17L22 USP17L15 | 1.96e-04 | 1299 | 206 | 27 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | USP17L7 PIGN USP17L21 CYP2A7 CYP2D6 USP17L1 USP17L20 SEC24A CFTR ATP10B USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 LRRC8C ATP8B3 USP17L4 STIM2 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P STARD3NL USP17L22 USP17L15 | 2.76e-04 | 1327 | 206 | 27 | GO:0042175 |
| Domain | HABP4_PAI-RBP1 | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 | 2.24e-26 | 16 | 202 | 14 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 | 2.24e-26 | 16 | 202 | 14 | IPR006861 |
| Domain | UCH | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP38 USP17L17 USP17L3 USP35 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP26 USP17L22 | 9.95e-22 | 71 | 202 | 19 | PF00443 |
| Domain | USP_2 | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP38 USP17L17 USP17L3 USP35 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP26 USP17L22 | 9.95e-22 | 71 | 202 | 19 | PS00973 |
| Domain | USP_3 | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP38 USP17L17 USP17L3 USP35 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP26 USP17L22 | 1.34e-21 | 72 | 202 | 19 | PS50235 |
| Domain | USP_dom | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP38 USP17L17 USP17L3 USP35 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP26 USP17L22 | 1.34e-21 | 72 | 202 | 19 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP38 USP17L17 USP17L3 USP35 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP26 USP17L22 | 1.34e-21 | 72 | 202 | 19 | IPR001394 |
| Domain | USP_CS | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP38 USP17L17 USP17L3 USP35 USP17L13 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP26 USP17L22 | 8.27e-21 | 66 | 202 | 18 | IPR018200 |
| Domain | USP_1 | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP38 USP17L17 USP17L3 USP35 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP26 USP17L22 | 2.70e-20 | 70 | 202 | 18 | PS00972 |
| Domain | ATPase_dyneun-rel_AAA | 1.22e-05 | 14 | 202 | 4 | IPR011704 | |
| Domain | AAA_5 | 1.22e-05 | 14 | 202 | 4 | PF07728 | |
| Domain | Choline_transpo | 1.23e-05 | 5 | 202 | 3 | PF04515 | |
| Domain | Choline_transptr-like | 1.23e-05 | 5 | 202 | 3 | IPR007603 | |
| Domain | ARM-type_fold | ARMC3 NBEAL1 TOGARAM1 HSPBP1 USP35 IPO8 TTI2 HUWE1 MEI1 VIRMA SDAD1 PPP4R3B INF2 BZW1 | 2.04e-05 | 339 | 202 | 14 | IPR016024 |
| Domain | NOP5_N | 1.16e-04 | 2 | 202 | 2 | IPR012974 | |
| Domain | NOP5NT | 1.16e-04 | 2 | 202 | 2 | PF08156 | |
| Domain | NR5_fam | 1.16e-04 | 2 | 202 | 2 | IPR016355 | |
| Domain | - | NLRP7 SMC1A CFTR NDST4 PEX1 RAB6C SAMD9L MDN1 GNAO1 DNA2 DNAH3 NSF MTHFD1L DHX37 DHX40 DNAH2 MYO18A HELQ DNAH1 DSEL | 1.78e-04 | 746 | 202 | 20 | 3.40.50.300 |
| Domain | NOSIC | 3.47e-04 | 3 | 202 | 2 | IPR012976 | |
| Domain | Nop | 3.47e-04 | 3 | 202 | 2 | PF01798 | |
| Domain | NOSIC | 3.47e-04 | 3 | 202 | 2 | SM00931 | |
| Domain | CDC48_domain_2-like | 3.47e-04 | 3 | 202 | 2 | IPR029067 | |
| Domain | - | 3.47e-04 | 3 | 202 | 2 | 4.10.1130.10 | |
| Domain | NOP | 3.47e-04 | 3 | 202 | 2 | PS51358 | |
| Domain | - | 3.47e-04 | 3 | 202 | 2 | 3.10.330.10 | |
| Domain | Nop_dom | 3.47e-04 | 3 | 202 | 2 | IPR002687 | |
| Domain | P-loop_NTPase | KIF21B NLRP7 SMC1A CFTR NDST4 PEX1 RAB6C SAMD9L MDN1 GNAO1 DNA2 DNAH3 NSF MTHFD1L DHX37 DHX40 DNAH2 MYO18A HELQ DNAH1 DSEL | 3.58e-04 | 848 | 202 | 21 | IPR027417 |
| Domain | Dynein_heavy_chain_D4_dom | 4.16e-04 | 14 | 202 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.16e-04 | 14 | 202 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.16e-04 | 14 | 202 | 3 | IPR013602 | |
| Domain | DHC_N2 | 4.16e-04 | 14 | 202 | 3 | PF08393 | |
| Domain | MT | 4.16e-04 | 14 | 202 | 3 | PF12777 | |
| Domain | AAA_8 | 4.16e-04 | 14 | 202 | 3 | PF12780 | |
| Domain | DHC_fam | 5.15e-04 | 15 | 202 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 5.15e-04 | 15 | 202 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 5.15e-04 | 15 | 202 | 3 | IPR004273 | |
| Domain | Chemokine_rcpt | 6.29e-04 | 16 | 202 | 3 | IPR000355 | |
| Domain | Asp_de-COase-like_dom | 1.14e-03 | 5 | 202 | 2 | IPR009010 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 | 1.94e-22 | 45 | 156 | 17 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L7 USP17L21 USP17L1 USP17L20 CFTR USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP26 RNF123 USP17L6P USP17L22 USP17L15 | 2.70e-14 | 191 | 156 | 20 | MM15289 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L1 USP17L20 CFTR USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP26 RNF123 USP17L22 USP17L15 | 4.36e-12 | 221 | 156 | 19 | M27578 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L7 USP17L21 USP17L1 USP17L20 CFTR USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP26 RNF123 USP17L6P USP17L22 USP17L15 | 1.03e-11 | 262 | 156 | 20 | MM15286 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L7 USP17L21 USP17L1 USP17L20 SPTA1 USP17L19 USP17L18 USP17L17 USP17L3 RASA4B USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 SPTBN4 RASA4 USP17L6P USP17L22 USP17L15 | 4.71e-11 | 318 | 156 | 21 | MM15278 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L1 USP17L20 CFTR USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP26 RNF123 USP17L22 USP17L15 | 8.09e-10 | 299 | 156 | 19 | M27574 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L7 B4GALT2 PIGN USP17L21 USP17L1 USP17L20 SEC24A SMC1A SPTA1 CFTR USP17L19 USP17L18 USP17L17 USP17L3 HERC2 USP17L13 USP17L4 USP17L2 USP17L12 NSF USP17L11 SAE1 USP17L5 SPTBN4 USP26 NOP58 RNF123 NUP155 SCG3 NR5A2 USP17L6P OGFOD1 EEF1AKMT2 NR5A1 GALNT5 USP17L22 CDH2 MUC5AC USP17L15 | 3.25e-08 | 1389 | 156 | 39 | MM15307 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | B4GALT2 PIGN USP17L21 USP17L1 USP17L20 SEC24A SMC1A SPTA1 CFTR USP17L19 USP17L18 USP17L17 USP17L3 HERC2 USP17L13 USP17L4 USP17L2 USP17L12 NSF USP17L11 USP17L24 SAE1 USP17L5 RWDD3 SPTBN4 USP26 NOP58 RNF123 NUP155 SCG3 NR5A2 OGFOD1 EEF1AKMT2 NR5A1 GALNT5 USP17L22 CDH2 MUC5AC USP17L15 | 1.62e-07 | 1475 | 156 | 39 | M19806 |
| Pathway | BIOCARTA_LIS1_PATHWAY | 4.91e-05 | 19 | 156 | 4 | M22005 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 2.08e-04 | 27 | 156 | 4 | M47755 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 2.72e-04 | 12 | 156 | 3 | MM14847 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 | 5.70e-35 | 21 | 210 | 17 | 8622927 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 | 5.70e-35 | 21 | 210 | 17 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 | 5.70e-35 | 21 | 210 | 17 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 | 5.70e-35 | 21 | 210 | 17 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 | 5.70e-35 | 21 | 210 | 17 | 12447969 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 | 5.70e-35 | 21 | 210 | 17 | 18980247 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 | 2.50e-34 | 22 | 210 | 17 | 9154835 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 | 3.25e-33 | 24 | 210 | 17 | 8995226 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 | 1.01e-32 | 25 | 210 | 17 | 21115691 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 | 2.90e-32 | 26 | 210 | 17 | 35816173 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 | 5.18e-32 | 33 | 210 | 18 | 20228807 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 | 1.09e-31 | 34 | 210 | 18 | 20403174 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 | 1.09e-31 | 34 | 210 | 18 | 14699124 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 | 1.09e-31 | 34 | 210 | 18 | 15780755 |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 | 1.09e-31 | 34 | 210 | 18 | 19188362 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 | 1.09e-31 | 34 | 210 | 18 | 11941478 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 | 1.09e-31 | 34 | 210 | 18 | 17109758 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 | 1.09e-31 | 34 | 210 | 18 | 20388806 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 | 1.09e-31 | 34 | 210 | 18 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 | 1.09e-31 | 34 | 210 | 18 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 | 1.09e-31 | 34 | 210 | 18 | 20368735 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 | 1.09e-31 | 34 | 210 | 18 | 10936051 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 | 1.09e-31 | 34 | 210 | 18 | 21448158 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 | 2.24e-31 | 35 | 210 | 18 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 | 2.24e-31 | 35 | 210 | 18 | 21239494 |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 | 4.46e-31 | 36 | 210 | 18 | 20147298 | |
| Pubmed | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 | 4.74e-31 | 29 | 210 | 17 | 32527007 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 | 8.64e-31 | 37 | 210 | 18 | 20228808 |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 PRAMEF13 USP17L6P USP17L22 USP17L15 | 8.25e-28 | 50 | 210 | 18 | 31806660 |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | 3.13e-14 | 10 | 210 | 7 | 24207026 | |
| Pubmed | 2.04e-13 | 12 | 210 | 7 | 24695638 | ||
| Pubmed | USP17L7 USP17L21 PRR5L USP17L1 USP17L20 TSPYL2 USP17L19 USP17L18 SHROOM4 SAMD9L USP17L17 USP17L3 ARMCX6 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 PRAMEF13 EGFL6 PLXNA4 USP17L6P USP17L22 USP17L15 | 5.69e-13 | 674 | 210 | 25 | 37196079 | |
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | 8.76e-13 | 14 | 210 | 7 | 11793228 | |
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | 1.25e-11 | 19 | 210 | 7 | 28067227 | |
| Pubmed | USP17L7 USP17L1 USP38 USP17L3 USP35 USP17L4 USP17L2 USP26 USP17L6P USP17L15 | 6.72e-11 | 81 | 210 | 10 | 12838346 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | USP17L7 SRP68 ZZEF1 SAMD9L MDN1 PKHD1 USP17L3 LRRC8C DNAH3 USP17L12 TTI2 DNAH2 HUWE1 PPP1R7 RNF123 PLXNA4 TNFAIP1 SERPINA9 | 6.26e-07 | 736 | 210 | 18 | 29676528 |
| Pubmed | Embryonic demise caused by targeted disruption of a cysteine protease Dub-2. | 8.64e-07 | 4 | 210 | 3 | 22984479 | |
| Pubmed | Choline transporter-like protein 4 (CTL4) links to non-neuronal acetylcholine synthesis. | 8.64e-07 | 4 | 210 | 3 | 23651124 | |
| Pubmed | 1.23e-06 | 14 | 210 | 4 | 9373155 | ||
| Pubmed | 2.15e-06 | 5 | 210 | 3 | 15715662 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | SMC1A SRP68 MDN1 HERC2 NEPRO IPO8 NOP56 DHX37 MYO18A MACROH2A1 VIRMA SDAD1 TEFM NOP58 POLR3B NUP155 MRPL46 | 4.20e-06 | 759 | 210 | 17 | 35915203 |
| Pubmed | 4.28e-06 | 6 | 210 | 3 | 11003698 | ||
| Pubmed | Polymorphism of metabolic genes and susceptibility to occupational chronic manganism. | 4.28e-06 | 6 | 210 | 3 | 12171760 | |
| Pubmed | 7.46e-06 | 7 | 210 | 3 | 9256245 | ||
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L12 USP17L11 | 8.37e-06 | 119 | 210 | 7 | 28625976 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | USP17L7 ATP5PO SMC1A SRP68 MICU1 USP38 HERC2 PRDX5 NEPRO USP17L2 NSF MTHFD1L DHX40 HUWE1 USP26 POLR3B NUP155 FANCI TNFAIP1 | 1.27e-05 | 1005 | 210 | 19 | 19615732 |
| Pubmed | PEX1 HSPBP1 MDN1 HERC2 DNA2 PKN3 IPO8 NSF MTHFD1L HUWE1 TUBGCP6 PPP4R3B NUP155 FANCI | 2.16e-05 | 606 | 210 | 14 | 36538041 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | ATP5PO SMC1A SRP68 NOP56 NSF MTHFD1L MACROH2A1 HUWE1 VIRMA NOP58 NUP155 CTH BZW1 MRPL46 | 2.19e-05 | 607 | 210 | 14 | 39147351 |
| Pubmed | KIF21B PLXND1 ZZEF1 FRMD4B USP38 SYNJ2 DNA2 SPG11 GPR107 NUAK2 TUBGCP6 PPP4R3B NUP155 | 2.26e-05 | 529 | 210 | 13 | 14621295 | |
| Pubmed | 3.55e-05 | 101 | 210 | 6 | 10997877 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 16216890 | ||
| Pubmed | CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway. | 3.63e-05 | 2 | 210 | 2 | 11448776 | |
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 25808902 | ||
| Pubmed | Therapeutic Potential for CFTR Correctors in Autosomal Recessive Polycystic Kidney Disease. | 3.63e-05 | 2 | 210 | 2 | 34329764 | |
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 11207030 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 28358580 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 23471216 | ||
| Pubmed | Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. | 3.63e-05 | 2 | 210 | 2 | 3123997 | |
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 17095585 | ||
| Pubmed | CCR9 AND CCR7 are overexpressed in CD4- CD8- thymocytes of myasthenia gravis patients. | 3.63e-05 | 2 | 210 | 2 | 26616645 | |
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 20554763 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 20962009 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 22121115 | ||
| Pubmed | Cdk5 regulates N-cadherin-dependent neuronal migration during cortical development. | 3.63e-05 | 2 | 210 | 2 | 31076103 | |
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 21129436 | ||
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 26530052 | ||
| Pubmed | CCR7 and CCR9 together recruit hematopoietic progenitors to the adult thymus. | 3.63e-05 | 2 | 210 | 2 | 19965655 | |
| Pubmed | Characterization of Cyp2d22, a novel cytochrome P450 expressed in mouse mammary cells. | 3.63e-05 | 2 | 210 | 2 | 11032406 | |
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 20040757 | ||
| Pubmed | Genome-wide suppressor screen identifies USP35/USP38 as therapeutic candidates for ciliopathies. | 3.63e-05 | 2 | 210 | 2 | 31723061 | |
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 38551960 | ||
| Pubmed | Enantiomer-specific activities of an LRH-1 and SF-1 dual agonist. | 3.63e-05 | 2 | 210 | 2 | 33335203 | |
| Pubmed | The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1. | 3.63e-05 | 2 | 210 | 2 | 15897460 | |
| Pubmed | Scavenger receptors mediate the role of SUMO and Ftz-f1 in Drosophila steroidogenesis. | 3.63e-05 | 2 | 210 | 2 | 23637637 | |
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 12972182 | ||
| Pubmed | Exogenous and endogenous determinants of blood trihalomethane levels after showering. | 3.63e-05 | 2 | 210 | 2 | 18197300 | |
| Pubmed | The relationship of chronic mucin secretion to airway disease in normal and CFTR-deficient mice. | 3.63e-05 | 2 | 210 | 2 | 9843919 | |
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 19594327 | ||
| Pubmed | Coding-noncoding gene expression in intrahepatic cholangiocarcinoma. | 3.63e-05 | 2 | 210 | 2 | 26297049 | |
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 15051713 | ||
| Pubmed | Liver receptor homologue-1 expression in ovarian epithelial and granulosa cell tumours. | 3.63e-05 | 2 | 210 | 2 | 23537609 | |
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 16041389 | ||
| Pubmed | LRH-1 May Rescue SF-1 Deficiency for Steroidogenesis: An in vitro and in vivo Study. | 3.63e-05 | 2 | 210 | 2 | 25896302 | |
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 20823062 | ||
| Pubmed | Cloning and sequence analysis of the human gene encoding steroidogenic factor 1. | 3.63e-05 | 2 | 210 | 2 | 8938589 | |
| Pubmed | 3.63e-05 | 2 | 210 | 2 | 31058195 | ||
| Pubmed | ATP5PO HSPBP1 MICU1 MDN1 HERC2 DNA2 STIM2 SLC4A7 IPO8 NOP56 NSF MTHFD1L MYO18A SPG11 MACROH2A1 TUBGCP6 NOP58 NUP155 INF2 GUSB LRRC1 MRPL46 | 1.06e-04 | 1487 | 210 | 22 | 33957083 | |
| Pubmed | 1.08e-04 | 3 | 210 | 2 | 21659540 | ||
| Pubmed | The alpha1-fetoprotein locus is activated by a nuclear receptor of the Drosophila FTZ-F1 family. | 1.08e-04 | 3 | 210 | 2 | 8668203 | |
| Pubmed | CD28 inhibits T cell adhesion by recruiting CAPRI to the plasma membrane. | 1.08e-04 | 3 | 210 | 2 | 25637021 | |
| Pubmed | 1.08e-04 | 3 | 210 | 2 | 25433169 | ||
| Pubmed | 1.08e-04 | 3 | 210 | 2 | 17586501 | ||
| Pubmed | A novel adenylyl cyclase sequence cloned from the human erythroleukemia cell line. | 1.08e-04 | 3 | 210 | 2 | 8476432 | |
| Pubmed | CYP2D6 genetic polymorphisms are associated with susceptibility to pituitary tumors. | 1.08e-04 | 3 | 210 | 2 | 16611538 | |
| Pubmed | 1.08e-04 | 3 | 210 | 2 | 22407040 | ||
| Pubmed | 1.08e-04 | 3 | 210 | 2 | 10521440 | ||
| Pubmed | Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India. | 1.08e-04 | 3 | 210 | 2 | 15588859 | |
| Pubmed | 1.08e-04 | 3 | 210 | 2 | 12417735 | ||
| Pubmed | 1.08e-04 | 3 | 210 | 2 | 2574001 | ||
| Pubmed | 1.08e-04 | 3 | 210 | 2 | 12657030 | ||
| Interaction | USP17L7 interactions | 1.39e-07 | 6 | 200 | 4 | int:USP17L7 | |
| Interaction | FLT3 interactions | USP17L21 USP17L20 SMC1A USP17L19 BANF1 USP17L18 MDN1 USP17L17 USP17L12 MTHFD1L USP17L11 MACROH2A1 HUWE1 NUP155 FANCI | 7.14e-07 | 318 | 200 | 15 | int:FLT3 |
| Cytoband | 4p16.1 | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 | 5.34e-17 | 79 | 210 | 13 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 | 4.08e-11 | 222 | 210 | 13 | chr4p16 |
| GeneFamily | Dyneins, axonemal | 4.68e-06 | 17 | 124 | 4 | 536 | |
| GeneFamily | CD molecules|C-C motif chemokine receptors | 3.65e-05 | 10 | 124 | 3 | 1091 | |
| GeneFamily | Ubiquitin specific peptidases | 5.88e-04 | 56 | 124 | 4 | 366 | |
| GeneFamily | EF-hand domain containing|Spectrins | 9.58e-04 | 7 | 124 | 2 | 1113 | |
| GeneFamily | Solute carriers | SLC26A8 SLC44A5 RHCG SLC4A7 SLC44A2 SLC44A4 SLC1A4 SLC39A12 SLCO2A1 | 1.61e-03 | 395 | 124 | 9 | 752 |
| GeneFamily | Plexins | 1.63e-03 | 9 | 124 | 2 | 683 | |
| GeneFamily | Cytochrome P450 family 2 | 1.76e-03 | 35 | 124 | 3 | 1001 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 2.03e-03 | 10 | 124 | 2 | 53 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 2.03e-03 | 10 | 124 | 2 | 830 | |
| GeneFamily | ATPase phospholipid transporting | 4.62e-03 | 15 | 124 | 2 | 1210 | |
| GeneFamily | DEAH-box helicases | 5.26e-03 | 16 | 124 | 2 | 500 | |
| GeneFamily | AAA ATPases | 5.75e-03 | 53 | 124 | 3 | 413 | |
| GeneFamily | Cadherin related | 5.93e-03 | 17 | 124 | 2 | 24 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 6.64e-03 | 18 | 124 | 2 | 91 | |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 | 2.49e-19 | 86 | 208 | 17 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 | 2.81e-17 | 112 | 208 | 17 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 | 1.29e-14 | 160 | 208 | 17 | MM1155 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 ZFYVE21 USP17L3 RASA4B USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 RASA4 GUSB USP17L6P USP17L22 USP17L15 | 5.60e-08 | 647 | 208 | 21 | MM981 |
| Coexpression | GSE14350_IL2RB_KO_VS_WT_TREG_UP | NCF4 HSPBP1 ADCY3 PTPN9 MDN1 SYNJ2 GNAO1 FASTKD1 POLR3B OGFOD1 CTH | 6.02e-07 | 199 | 208 | 11 | M3421 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L7 USP17L21 USP17L1 USP17L20 MFSD6 USP17L19 USP17L18 SLC26A8 ERP27 USP17L17 SYNJ2 USP17L3 CCR1 USP17L13 USP17L4 USP17L2 USP17L12 UBL3 USP17L11 USP17L5 NOP58 POLR3B USP17L6P USP17L22 USP17L15 | 1.51e-06 | 1072 | 208 | 25 | MM1031 |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | PLXND1 FRMD4B SHROOM4 PCDH15 PKN3 ANO2 MTHFD1L HMCN1 SLCO2A1 TNFAIP1 | 2.14e-08 | 194 | 202 | 10 | b6cc849fa08599bff9839ef382d190cc964e273e |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-07 | 184 | 202 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-07 | 184 | 202 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-07 | 184 | 202 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | (08)_PNEC-(2)_48hpi|(08)_PNEC / shred by cell type and Timepoint | 2.88e-07 | 142 | 202 | 8 | e95d34170f5053678e0dd9793e68d93c03b05822 | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 3.20e-07 | 198 | 202 | 9 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 3.20e-07 | 198 | 202 | 9 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 3.20e-07 | 198 | 202 | 9 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.48e-07 | 200 | 202 | 9 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 2.13e-06 | 185 | 202 | 8 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.30e-06 | 187 | 202 | 8 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr-Polydendrocyte.Tnr.Opalin_(Opalin)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.31e-06 | 84 | 202 | 6 | c798f5831711749273b2d47d645ab242839295a9 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.31e-06 | 84 | 202 | 6 | 38981522315205c356a7fa269a5e3c3331c9ee83 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 2.91e-06 | 193 | 202 | 8 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.79e-06 | 200 | 202 | 8 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.79e-06 | 200 | 202 | 8 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.79e-06 | 200 | 202 | 8 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.30e-06 | 159 | 202 | 7 | b1d5ebd0c186b6d0279dab20d8f3b4a915acdc1f | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT1_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-05 | 117 | 202 | 6 | f3c77b234e461566aac81ede0ef84008c9a9f51e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.61e-05 | 176 | 202 | 7 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.73e-05 | 178 | 202 | 7 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.86e-05 | 180 | 202 | 7 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.86e-05 | 180 | 202 | 7 | b234668bf181522807470e396792e1b54890b719 | |
| ToppCell | COVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class | 1.99e-05 | 182 | 202 | 7 | 877b6e611626628e709568747512f2827ebb2795 | |
| ToppCell | P03-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.14e-05 | 184 | 202 | 7 | 8880ff36c243cc60a524d74934d000aef26a70ac | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 2.22e-05 | 185 | 202 | 7 | 4abe04198ab5047c211f8d09cdb9650fa52a3cd6 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|COPD / Disease state, Lineage and Cell class | 2.29e-05 | 186 | 202 | 7 | 23c7d0e8372a71546d687278b985f761d282f92f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.37e-05 | 187 | 202 | 7 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | 15-Trachea-Epithelial-Secretory_progenitor|Trachea / Age, Tissue, Lineage and Cell class | 2.37e-05 | 187 | 202 | 7 | be9fce9e74b2f170a2067f1b31d802912a578329 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 188 | 202 | 7 | c2c51c6526defe2600302901159b8abbb58d7595 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 2.54e-05 | 189 | 202 | 7 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.54e-05 | 189 | 202 | 7 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3-Excitatory_Neuron.Slc17a7.Pvrl3-Nos1_(CA3_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.62e-05 | 128 | 202 | 6 | 9128b633879d21de2ebe651384cfec6d2c3c2932 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-05 | 190 | 202 | 7 | b057bea6e55cef872290893b6e439bbcdcee2f2e | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.63e-05 | 190 | 202 | 7 | 3f0c7d130f66faea778fe567604edf1b4cdf85b3 | |
| ToppCell | droplet-Lung-18m-Epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.72e-05 | 191 | 202 | 7 | 1b59f1cad6c1a6a5938afa9195164918e3ff4e86 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.72e-05 | 191 | 202 | 7 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | severe-Lymphocytic-CD4_T_cells_3|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.72e-05 | 191 | 202 | 7 | afff6bfae9a2f1e17d2731315e7fe63c4601679f | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 2.81e-05 | 192 | 202 | 7 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-05 | 192 | 202 | 7 | 56b021c297a21dff357531f21e2464f85186106d | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 2.81e-05 | 192 | 202 | 7 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-05 | 192 | 202 | 7 | 28eb3a5728e8901bcb5ba12f6b009f41b065fa37 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.81e-05 | 192 | 202 | 7 | c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.90e-05 | 193 | 202 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.90e-05 | 193 | 202 | 7 | 9ba688b35a9ead5d04691b3f3f15484f02dbbd0d | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.90e-05 | 193 | 202 | 7 | 01c71aa48875b5ad6c50cc810a72862e72f26ad0 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.90e-05 | 193 | 202 | 7 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | IPF-Endothelial-VE_Venous|IPF / Disease state, Lineage and Cell class | 2.90e-05 | 193 | 202 | 7 | 29a655fa80feaabe846c90a28363b037e22d24ae | |
| ToppCell | IPF-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 2.90e-05 | 193 | 202 | 7 | ef66a46e7ab44fcc4005a23416e6da478a4cce37 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 3.00e-05 | 194 | 202 | 7 | 8dcde77767b23e75360adb316cdccf56a00e3726 | |
| ToppCell | IPF-Endothelial|IPF / Disease state, Lineage and Cell class | 3.00e-05 | 194 | 202 | 7 | 9591993aa2dcba3d09a0f1ea8b8f2439c26482d6 | |
| ToppCell | 18-Airway-Epithelial-Epithelial|Airway / Age, Tissue, Lineage and Cell class | 3.00e-05 | 194 | 202 | 7 | d3c90e1f1228f8ba0ba56105c6cf4f302c388f28 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 3.10e-05 | 195 | 202 | 7 | 120296531bbc8080dcabacbd64733cc1dc34603a | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 3.10e-05 | 195 | 202 | 7 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|IPF / Disease state, Lineage and Cell class | 3.10e-05 | 195 | 202 | 7 | 2c3ad3cb79f11119ac69c413a938d21199145040 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 3.10e-05 | 195 | 202 | 7 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-05 | 196 | 202 | 7 | 8ad8efb631164b46f0c082572270188e5ead20bf | |
| ToppCell | Fetal_29-31_weeks-Endothelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.20e-05 | 196 | 202 | 7 | 3981f6c7487598f4f7ce4650ac0ac5bd41481d66 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-05 | 196 | 202 | 7 | 9606ea7e42f707e69ea891b3521037613b9675f5 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-A_(Artery)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.31e-05 | 197 | 202 | 7 | 951f18f326967206adbbfc422cce9eea3d2e0854 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-A_(Artery)|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.31e-05 | 197 | 202 | 7 | 7caa2c86dc4d50b57a7db8f7278d1588282ad6db | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 3.31e-05 | 197 | 202 | 7 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 3.31e-05 | 197 | 202 | 7 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | PSB|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.42e-05 | 198 | 202 | 7 | 4e6b0d1abc55d7a0d89bd7ecf0f13dc5bed66626 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.53e-05 | 199 | 202 | 7 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | 367C-Endothelial_cells-Endothelial-A_(Artery)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.53e-05 | 199 | 202 | 7 | c2d85f80037f209a4a329790f475d9f98f590262 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Bronchial_vessel|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.53e-05 | 199 | 202 | 7 | 53b6a661d381b1ed3ea96e61e8bd1750de7d9fda | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Bronchial_vessel|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.53e-05 | 199 | 202 | 7 | 9c753043024871b1f1436fc39defac4da85e10cd | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Bronchial_vessel-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.53e-05 | 199 | 202 | 7 | d017dd91f9b10038f1f83753a766e534da2dbe89 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-A_(Artery)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.53e-05 | 199 | 202 | 7 | 29ed081bd5204a32068b420f2244f3704891547b | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.64e-05 | 200 | 202 | 7 | cf191104484bfb2b9f87de416b9453135f8833c1 | |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.64e-05 | 200 | 202 | 7 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-05 | 145 | 202 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 6.60e-05 | 151 | 202 | 6 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.62e-05 | 155 | 202 | 6 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.62e-05 | 155 | 202 | 6 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-04 | 164 | 202 | 6 | 9e16e52f5a634585f26021bcce9b5d5992ff6db0 | |
| ToppCell | 11.5-Airway-RBC-RBC|Airway / Age, Tissue, Lineage and Cell class | 1.08e-04 | 165 | 202 | 6 | 8618b2c5659aa70c7c9d6e51a227ac612b4ad17b | |
| ToppCell | 11.5-Airway-RBC|Airway / Age, Tissue, Lineage and Cell class | 1.08e-04 | 165 | 202 | 6 | 46042340a373adaf1c439b2301e02fbae3e31a4f | |
| ToppCell | COVID-19_Mild-PLT_2|World / Disease Group and Platelet Clusters | 1.23e-04 | 169 | 202 | 6 | 6abfdc8b437f19c03b408bedc245059d28c6ba6a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-04 | 169 | 202 | 6 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.27e-04 | 170 | 202 | 6 | fefb07a7e308b620f946b9ff2b01e1796446fe38 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.31e-04 | 171 | 202 | 6 | fe27bf581c75ef33c2848878e51ed16b275a4c8e | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.31e-04 | 171 | 202 | 6 | 25c1979e972c959e1ce4c57804f976f53a247ad7 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 173 | 202 | 6 | 6d2ceba4f89a228600e2b40aba81bb0eb81578c0 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-04 | 174 | 202 | 6 | 4a18b51501eaaeb7907e99316ba8ae15b2c7d529 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-04 | 174 | 202 | 6 | 42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-04 | 175 | 202 | 6 | 182e45f5c02214d6b9f317ff5dc43af8b42de978 | |
| ToppCell | RSV-Healthy-2|RSV / Virus stimulation, Condition and Cluster | 1.48e-04 | 175 | 202 | 6 | 0e97189585b7afaf3bd622c3ef10c86412393829 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.48e-04 | 175 | 202 | 6 | 89bf89466191da14896ed8928027f5b911436c22 | |
| ToppCell | RSV-Healthy-2|Healthy / Virus stimulation, Condition and Cluster | 1.48e-04 | 175 | 202 | 6 | c47440c0b0513e67fe13b85f10dd8a8d42d0e9a3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-04 | 176 | 202 | 6 | cb21342dd135cc80a50aafe7bf8bf31265db68dd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 178 | 202 | 6 | 5f779a66aa42d1d8e8af17b4a08d5dcc733efd4c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-04 | 178 | 202 | 6 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-04 | 180 | 202 | 6 | 755050226eeb1991ee7f0d15e39d0458f3e4a791 | |
| ToppCell | Endothelial-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.78e-04 | 181 | 202 | 6 | 4fe0215d08f03d4e24749d70fce01b7aa22906fd | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 1.83e-04 | 182 | 202 | 6 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.83e-04 | 182 | 202 | 6 | 1aea96ee211f7b9caef7fd385233f51be6021a73 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.83e-04 | 182 | 202 | 6 | b427e43ee523a3ea9eca3207f3d82042f10f022a | |
| ToppCell | T_cells-Resident_memory_CD8+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.83e-04 | 182 | 202 | 6 | 111d434b89902ec11fb07f41b8ee1a98f3991b61 | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 | 1.44e-27 | 46 | 204 | 18 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 | 7.67e-24 | 69 | 204 | 18 | DOID:1682 (implicated_via_orthology) |
| Disease | CRANIOOSTEOARTHROPATHY | 4.76e-05 | 2 | 204 | 2 | C2678439 | |
| Disease | HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1 | 4.76e-05 | 2 | 204 | 2 | C4551679 | |
| Disease | Osteoarthropathy, Primary Hypertrophic | 4.76e-05 | 2 | 204 | 2 | C0029411 | |
| Disease | Hereditary clubbing | 4.76e-05 | 2 | 204 | 2 | C0345408 | |
| Disease | Hypertrophic Osteoarthropathy, Primary, Autosomal Dominant | 4.76e-05 | 2 | 204 | 2 | C2674695 | |
| Disease | primary hypertrophic osteoarthropathy (is_implicated_in) | 4.76e-05 | 2 | 204 | 2 | DOID:14283 (is_implicated_in) | |
| Disease | solanidine measurement | 2.83e-04 | 4 | 204 | 2 | EFO_0800966 | |
| Disease | gestational trophoblastic neoplasm (is_implicated_in) | 2.83e-04 | 4 | 204 | 2 | DOID:3590 (is_implicated_in) | |
| Disease | Complete hydatidiform mole | 2.83e-04 | 4 | 204 | 2 | C0678213 | |
| Disease | X-24020 measurement | 4.69e-04 | 5 | 204 | 2 | EFO_0022128 | |
| Disease | Choledochal Cyst, Type I | 4.69e-04 | 5 | 204 | 2 | C0009439 | |
| Disease | Choledochal Cyst, Type II | 4.69e-04 | 5 | 204 | 2 | C1257796 | |
| Disease | Choledochal Cyst, Type III | 4.69e-04 | 5 | 204 | 2 | C1257797 | |
| Disease | Choledochal Cyst, Type IV | 4.69e-04 | 5 | 204 | 2 | C1257798 | |
| Disease | Choledochal Cyst, Type V | 4.69e-04 | 5 | 204 | 2 | C1257799 | |
| Disease | Choledochal Cyst | 4.69e-04 | 5 | 204 | 2 | C0008340 | |
| Disease | rheumatoid arthritis (is_implicated_in) | 7.03e-04 | 58 | 204 | 4 | DOID:7148 (is_implicated_in) | |
| Disease | triglyceride measurement, multiple sclerosis | 9.76e-04 | 7 | 204 | 2 | EFO_0004530, MONDO_0005301 | |
| Disease | protein FAM177A1 measurement | 1.30e-03 | 8 | 204 | 2 | EFO_0801948 | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 1.66e-03 | 9 | 204 | 2 | C0085548 | |
| Disease | Asthma, Occupational | 2.06e-03 | 10 | 204 | 2 | C0264423 | |
| Disease | Fanconi anemia (is_implicated_in) | 2.06e-03 | 10 | 204 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 2.51e-03 | 11 | 204 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | Lenticulostriate Disorders | 3.00e-03 | 12 | 204 | 2 | C0750951 | |
| Disease | Extrapyramidal Disorders | 3.00e-03 | 12 | 204 | 2 | C0015371 | |
| Disease | Prenatal Exposure Delayed Effects | 3.00e-03 | 12 | 204 | 2 | C0033054 | |
| Disease | Basal Ganglia Diseases | 3.00e-03 | 12 | 204 | 2 | C0004782 | |
| Disease | respiratory system disease | 3.43e-03 | 145 | 204 | 5 | EFO_0000684 | |
| Disease | esophageal adenocarcinoma, Barrett's esophagus, sex interaction measurement | 3.53e-03 | 13 | 204 | 2 | EFO_0000280, EFO_0000478, EFO_0008343 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 3.53e-03 | 13 | 204 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | gastric ulcer (implicated_via_orthology) | 4.10e-03 | 14 | 204 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | wet macular degeneration | 4.10e-03 | 14 | 204 | 2 | EFO_0004683 | |
| Disease | Inhalant adrenergic use measurement | 4.49e-03 | 96 | 204 | 4 | EFO_0009941 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 4.71e-03 | 15 | 204 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | glycerate measurement | 4.71e-03 | 15 | 204 | 2 | EFO_0021029 | |
| Disease | asthma (is_implicated_in) | 4.80e-03 | 157 | 204 | 5 | DOID:2841 (is_implicated_in) | |
| Disease | age at menopause | 5.22e-03 | 302 | 204 | 7 | EFO_0004704 | |
| Disease | Alpha ketoglutarate measurement | 5.35e-03 | 16 | 204 | 2 | EFO_0010457 | |
| Disease | level of Phosphatidylcholine (18:0_18:2) in blood serum | 5.35e-03 | 16 | 204 | 2 | OBA_2045090 | |
| Disease | susceptibility to rubella infection measurement | 5.61e-03 | 52 | 204 | 3 | EFO_0008418 | |
| Disease | human papilloma virus infection, oropharynx cancer | 5.92e-03 | 53 | 204 | 3 | EFO_0001668, EFO_1001931 | |
| Disease | immature granulocyte count | 6.04e-03 | 17 | 204 | 2 | EFO_0803542 | |
| Disease | Idiopathic hypogonadotropic hypogonadism | 6.77e-03 | 18 | 204 | 2 | C0342384 | |
| Disease | esophageal adenocarcinoma | 6.77e-03 | 18 | 204 | 2 | EFO_0000478 | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 6.77e-03 | 18 | 204 | 2 | OBA_2045065 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLNLKKAISAAAEIF | 361 | Q9BXU7 | |
| ALKLLLEELNVFRGK | 206 | Q8NFU1 | |
| RAKLLNVGFLEALKE | 191 | O60909 | |
| EFILKLKAEVQRLLG | 541 | O94986 | |
| NFISFTLKLVLKGQI | 186 | P11597 | |
| EFGLILVQRKALTSK | 376 | Q8IUX8 | |
| LKDINFKIERGQLLA | 441 | P13569 | |
| LLFLKGFSESERNKL | 136 | Q7L1Q6 | |
| KNIELFDKLSLRFNG | 181 | Q13829 | |
| KIAKSLALILFLFAL | 231 | P30542 | |
| EIVKSFLFQLLKGLG | 101 | Q00535 | |
| LLAQTVFLFLVAKKV | 281 | P07510 | |
| LKSFIQASLALLFGK | 76 | Q8NHS2 | |
| LSTKSLFLGQKLNLI | 186 | O75367 | |
| FLLLAAQVLLVEGKK | 11 | Q14512 | |
| NFKGIKIATLFLLGK | 106 | Q9Y5Z6 | |
| VAGLVKITLKDFLQA | 591 | Q8NB90 | |
| VKFRNDLFKLFKDLG | 331 | P32248 | |
| EIFLKNLKLFTLAES | 326 | P32929 | |
| TIFAFEGILIKKLLR | 91 | Q16548 | |
| KLALVINGDFLDKLL | 816 | O60423 | |
| INGDFLDKLLVSLRK | 821 | O60423 | |
| FGILASNNDVKKLLR | 91 | Q5W041 | |
| ERLILKAFLLKFVNA | 621 | Q9NQ90 | |
| GRNLDKDILKQLFIA | 361 | Q5RIA9 | |
| EFSEIQLARLKKLGI | 531 | Q6UB35 | |
| LCGFLQKSFLALEKR | 246 | A6NI56 | |
| DLSKCLFIQGKLLFA | 126 | Q7L4S7 | |
| ISGDEFLNFLLKLNK | 351 | Q8WWH4 | |
| IFQGKLEKKFLELTQ | 1006 | O94823 | |
| LKSFLSQGQVLKLEA | 161 | P48047 | |
| LVKLQKFGENLDLRI | 476 | Q8IWA6 | |
| TLVRLFLKAKFENGN | 1266 | Q6ZS30 | |
| LKLFLGQGLAKDFLD | 311 | O43374 | |
| LKLFLGQGLAKDFLD | 311 | C9J798 | |
| LRKFKLVFLGEQSVA | 11 | Q9H0N0 | |
| LRKFKLVFLGEQSVA | 11 | Q53S08 | |
| GITAAINLAKLKLFR | 481 | Q5VW38 | |
| ANFELDLGKKVLNLL | 161 | P43378 | |
| KSFKDLQLLQGSKFL | 336 | Q9NVI1 | |
| AVAGFLLLLKNFKVL | 536 | Q9NVI1 | |
| EALFLLLSNFTGLKL | 351 | Q8N543 | |
| VQILGAEKALFRALK | 316 | Q9Y2X3 | |
| VQILGAEKALFRALK | 326 | O00567 | |
| FLLKLFQSIEKEGIL | 491 | O00370 | |
| SKFLNGLEILLAKAQ | 3771 | Q9NU22 | |
| GDLIKFFKTLQDLLK | 91 | Q8IV33 | |
| LSRNAFAGLLKLKEL | 196 | Q86VH4 | |
| LILAKSKGFDVFNAL | 441 | O60551 | |
| LEKTSLNIKRDFLGF | 321 | Q8IWI9 | |
| GIDTILKLASKNFLL | 1671 | O95714 | |
| ILFVKTRALVDALKN | 631 | O95786 | |
| GRNLDKDILKQLFIA | 361 | Q8IUF1 | |
| GRNLDKDILKQLFIA | 361 | Q9BRT8 | |
| DLKGKLTIKNFLEFQ | 286 | Q9BPX6 | |
| LFSKLGDLLHKLQFV | 1276 | A6NKB5 | |
| GLKLFAQLINNKVFL | 1351 | Q9HCM2 | |
| KGTLQKFLDDLFKAI | 1711 | Q9Y4D7 | |
| LELLRNLKSKSGLAF | 391 | O43526 | |
| QSLQADLKLAFKRIG | 1916 | Q92614 | |
| LLKNLFKIFCLDGVK | 41 | P40261 | |
| ALLKEFQLLLKGAVR | 131 | Q4G0M1 | |
| RLLLDNFLKASIDKG | 1031 | O75037 | |
| KLELNFKAGDVIFLL | 186 | Q15080 | |
| FKAGDVIFLLSRINK | 191 | Q15080 | |
| LVFSFNEKLFGLLVK | 136 | P46459 | |
| LLTIGFLFKKLGRQL | 456 | Q96RT7 | |
| SKAIKIFLGGFELKL | 961 | P98088 | |
| KLIFIDAISFLSGKR | 281 | Q9H3R1 | |
| NRDAFFKTLAKLGIL | 351 | Q5MIZ7 | |
| DRFKKGKIVLLFSLL | 126 | Q6ZSS7 | |
| QKLTLEKVFRGLLLL | 136 | Q8TAA5 | |
| NIIRLFLKKGLVNDL | 2211 | Q7Z6Z7 | |
| ALTFLKSLLEIFQKE | 121 | P15248 | |
| LKGSFIELRKALFQL | 131 | Q86X67 | |
| TFLDAKKSLNLNIFL | 631 | Q27J81 | |
| FQLVKLRKLGLSDNE | 56 | Q9BTT6 | |
| ITGNFKSLQAKLERL | 1376 | O75694 | |
| FKILLNGRKLVIAQA | 1781 | Q96RW7 | |
| EKAILQRGKFLLSTL | 491 | Q5TIA1 | |
| SFEILQLLSKLKGFL | 241 | Q49AM1 | |
| LLAKGLFFVEEKIKL | 101 | Q6MZQ0 | |
| TKKRSLLGTQVFFLL | 81 | Q9NQ84 | |
| FGNLSLIIIIFKKQR | 51 | Q99463 | |
| VNLAELFKGKKGVLF | 76 | P30044 | |
| IDRNELFKFLDGKLL | 1321 | Q96QU1 | |
| TIFKLAAFILQEAKG | 176 | Q9Y2L6 | |
| LHIFSILIGQKKLEL | 2811 | Q9P2D7 | |
| AQELVKLLNELFGKF | 321 | Q08828 | |
| QLFLKKSFITQDLGL | 611 | Q6ZP82 | |
| VAKKLGALLDSFITI | 86 | Q96C57 | |
| KKKAFNFLGEIIGLI | 1926 | Q9UFH2 | |
| FEKDKLLFSLLLTIG | 3366 | Q8TD57 | |
| KLFQALKLNLFGLVL | 196 | P32246 | |
| ERTAKGTLLLDLNKF | 356 | Q6ZTQ4 | |
| QAFKLLQGLEDFIAK | 236 | P20853 | |
| LAGKVLRFQKAFLTQ | 236 | P10635 | |
| LLCLEGNFSQKILKV | 906 | Q7Z7M9 | |
| GLSNIKLKVEDFLNL | 126 | Q5JPI9 | |
| KGSNLFKLEVRLLDA | 251 | P08236 | |
| KSAVLTLKVILGFFL | 211 | P51686 | |
| LKAIFNIKFLARLDS | 631 | Q53R41 | |
| GRNLDKDILKQLFIA | 361 | Q5JTY5 | |
| GRNLDKDILKQLFIA | 361 | Q4V339 | |
| VKLLNELFARFDKLA | 341 | O60266 | |
| TLLGITLFICLKKEQ | 116 | Q49MI3 | |
| SLFKENNITGKRLLL | 366 | Q9NYL2 | |
| AKLFQGKILFILVDS | 186 | Q96DN0 | |
| KVTDFLFLLGKLLIV | 596 | Q8IWA5 | |
| LDKVTDLLLFFGKLL | 591 | Q53GD3 | |
| INKLLDAKSLGLKVF | 221 | Q8NCS7 | |
| LLKIIQLGLTFTNEK | 71 | Q9UFF9 | |
| SVSLLIFKDLKLRGF | 296 | Q9BV79 | |
| FFGVQQKVLLKEKSL | 781 | Q8TDG4 | |
| LGQFLVLKKDEDLFR | 46 | O75531 | |
| AVDNILLKLAKFKIG | 681 | P51530 | |
| GVLLKEIQKDFLLLR | 351 | Q8IY37 | |
| TTDILFGLLKKLFQE | 181 | Q8IX18 | |
| LAQANKLRTGLFKID | 3001 | Q9P225 | |
| TLTNLESLFLGKNKI | 206 | Q15435 | |
| LVEIFLQKGLSLISK | 316 | Q504Y0 | |
| DRFSFIVKNLSLLIK | 81 | Q9BZW8 | |
| ESQLVFLDKFILKNG | 341 | Q8IZU8 | |
| KLVLTTLDFQKALRG | 806 | O43933 | |
| FAQLNLKIKFLEAGI | 661 | P19022 | |
| LFLKDGKLKLSLFQA | 421 | Q96NU0 | |
| FRDFLLVKLINGEKA | 371 | Q5VVW2 | |
| SVFLGLEHLQLLKIK | 261 | Q5VWM6 | |
| KLDNLLLDAQGFLKI | 686 | Q6P5Z2 | |
| TRKLKLAVLNSFFNL | 176 | Q6QHF9 | |
| VIGSLAEILLKKSLF | 436 | O15397 | |
| FAEALLLKGAKVALV | 21 | P15428 | |
| LKFLVLFSLDVKNLE | 451 | O00482 | |
| LLEDKFLQNKAFLTG | 146 | P30711 | |
| LKVKSAFLLQNLLVG | 246 | Q9NZL4 | |
| NLGAKVFFFKALLLT | 226 | Q9H2W6 | |
| LKFIILFSLDLKFLN | 371 | Q13285 | |
| VSSLKGIQLFDRIKL | 1046 | Q9Y6M7 | |
| NKEILILGISAFIFL | 496 | Q6UWJ1 | |
| SFILILGNSKLKQTF | 281 | Q9NYW6 | |
| NFFDGVKQEAIKLLL | 471 | O15056 | |
| LKKQLREVLQFVGLS | 1406 | Q8IVG5 | |
| LFVLALLKQKSFQTG | 901 | O95486 | |
| LVSSFLLIFLGKKIA | 366 | Q96RN1 | |
| LDGKEALKRLQQFFK | 536 | Q5VWT5 | |
| IDTSIILFLNKKDLF | 261 | P09471 | |
| FAAKGINKLLNKLFL | 246 | Q6NW34 | |
| FILAAIAGSVKLLKL | 96 | Q05823 | |
| AGAFSKLNKLKVLIL | 151 | Q9H156 | |
| DVLGTLLKVFQALFL | 51 | Q8NE22 | |
| LLKGRLALTGKINLF | 226 | Q6ZNX1 | |
| QEALILIKGSFRILK | 71 | Q9ULL8 | |
| FLLQVLLKFRTDKGR | 241 | Q9UBE0 | |
| DLQKLSLQVAKGVFL | 616 | Q8WX94 | |
| GKELVKQFLFDSILK | 296 | Q96QE5 | |
| LRFFLLGNKSTSKLL | 3481 | P08F94 | |
| TKILVAALTFFLGKD | 211 | Q9NVU7 | |
| ILKLNGKFSQTALEL | 501 | Q9H093 | |
| KKLLFAGSRSQLVQL | 481 | Q9C0C4 | |
| KIDKVRIFLLGLADN | 306 | Q9UHB9 | |
| LFVKKELQLQANFLG | 136 | Q86WD7 | |
| KKGALFNLLVILISE | 436 | Q8IXR9 | |
| QVDFGFLKQLLQLKF | 116 | Q8IYJ2 | |
| LAGKVLRFQKAFLTQ | 236 | A0A087X1C5 | |
| TLKALNDFQKLLGDI | 261 | P63136 | |
| VIAGLSTFLNKFLEK | 341 | Q92959 | |
| LIGIGLNLVFDNLKK | 721 | Q96JI7 | |
| LKKLLSLLNGFVAVS | 11 | Q9UKR8 | |
| LILVLKRFSDVAGNK | 276 | A6NCW0 | |
| TAGLKKLFSEFVLAL | 251 | Q9Y3V2 | |
| LEAVNIKAGKAFLRL | 226 | Q9H2G4 | |
| NLRKFGTLKELVLEA | 66 | P0CB47 | |
| QFGQLALDLLEKAFK | 671 | Q9BX84 | |
| LILVLKRFSDVAGNK | 276 | A6NCW7 | |
| GNDFAAIKLQVIKLI | 31 | O14609 | |
| KLGFLGFLLNAESLK | 571 | Q9H5L6 | |
| EKAAQVGLLFLKLLG | 111 | Q6NXR4 | |
| RQKLQLKALDVVLFG | 191 | Q9P246 | |
| LVLFALVLGVALKKL | 226 | P43007 | |
| NLRLILVSGKTKEFL | 11 | O95164 | |
| KSRKFLLSNVLFDVL | 416 | Q5XPI4 | |
| FLLAKVILSKLFSQG | 136 | O95772 | |
| IIALLKGLAAVKKFS | 286 | Q9P2H5 | |
| LLVEKRQFKSFLGDL | 981 | Q6IQ55 | |
| LILVLKRFSDVTGNK | 276 | D6R9N7 | |
| LILVLKRFSDVTGNK | 276 | A8MUK1 | |
| SFLKQLIAGKLQESV | 41 | Q96S82 | |
| LILVLKRFSDVTGNK | 276 | D6R901 | |
| LILVLKRFSDVTGNK | 276 | C9JLJ4 | |
| LEKLGILIKARNFLV | 121 | Q14683 | |
| KGNLEVLLFSIQSKL | 366 | Q9H254 | |
| LKFNISLQKDALIGV | 416 | Q9P273 | |
| LILVLKRFSDVTGNK | 276 | D6RCP7 | |
| GQLLSLLFEDLFKKF | 366 | Q9NW08 | |
| LTLEKGDQLLRALKF | 146 | P02549 | |
| LILVLKRFSDVAGNK | 276 | Q7RTZ2 | |
| LQFSKKNLLELCLKG | 111 | A6NFE2 | |
| KVIAGFSLLNLLFKQ | 311 | Q9HCJ6 | |
| VFLNGLAQLLTTKKL | 906 | O95427 | |
| IALLKGLAAVQKFTI | 291 | Q8NB14 | |
| EFILLNLLKVKDAGG | 166 | Q9UBD6 | |
| LILVLKRFSDVTGNK | 276 | C9JPN9 | |
| GNDFAAIKLQVIKLI | 31 | A2RUG3 | |
| VLLSFVISELFKGKL | 1606 | Q6ZT12 | |
| LILVLKRFSDVTGNK | 276 | Q0WX57 | |
| LVLFLVKAVKGFSSL | 1651 | O43149 | |
| DKQLKVLLSGATFLV | 111 | Q9BQ24 | |
| LILVLKRFSDVTGNK | 276 | P0C7H9 | |
| LILVLKRFSDVTGNK | 276 | Q6QN14 | |
| LKLITGLLNAKDFRD | 1491 | Q9Y4F4 | |
| LILVLKRFSDVTGNK | 276 | D6RA61 | |
| LILVLKRFSDVTGNK | 276 | C9J2P7 | |
| LILVLKRFSDVTGNK | 276 | D6RBQ6 | |
| DVLKFLAQSQKGLLF | 706 | Q69YN4 | |
| AVFDKIVSKLLNLGL | 166 | Q8WXD2 | |
| LILVLKRFSDVTGNK | 276 | Q6R6M4 | |
| SFIKDFLAKNLIIVI | 196 | P19075 | |
| LILVLKRFSDVTGNK | 276 | D6RJB6 | |
| VFGLLKQRKLNFLEI | 386 | Q9P1Q0 | |
| TLLLFKDVKNAGDLR | 16 | Q9Y3C4 | |
| LILVLKRFSDVTGNK | 276 | C9JVI0 | |
| GFKNLVLERKLQALS | 361 | O95995 | |
| LSFLKENLKVLSVKF | 486 | Q8TDW0 |